Current Signal Transduction Therapy

In recent years, a breakthrough has occurred in our understanding of the molecular pathomechanisms of human diseases, whereby most of our diseases are related to intra- and intercellular communication disorders. The concept of signal transduction therapy has become the forefront of modern drug research, and a multidisciplinary approach is being used to identify and treat signaling disorders.
The journal publishes timely in-depth/mini-reviews, research articles, and drug clinical trial studies in the field of signal transduction therapy. Thematic issues are also published to cover selected areas of signal transduction therapy. Coverage of the field includes genomics, proteomics, medicinal chemistry and the relevant diseases involved in signaling, e.g., cancer and neurodegenerative and inflammatory diseases. Current Signal Transduction Therapy is an essential journal for all researchers involved in drug design and discovery.
Current Signal Transduction Therapy is an international, peer-reviewed journal on all aspects of signal transduction therapy published quarterly (print & online) by Bentham Science Publishers.